Recently, Chang et al. found that DPP9 inhibited the ubiquitination degradation of NRF2 by binding KEAP1 in Clear Cell Renal Cell Carcinoma, thereby regulating the protein level of NRF2 [25]. This evidence concerns the gene DPP9 and clear cell renal carcinoma.